MPI8

Overview

MPI8 (TG0205221) is an inhibitor of the major protease of SARS-CoV-2 ( MPro ) with high antiviral activity. MPI8 exerts its antiviral effect by dual and selective inhibition of SARS-CoV-2 MPro and host cell cysteine protease L ( cathepsin L ). MPI8 can be used in clinical studies of COVID-19.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Infection | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > Cathepsin | Products > Signaling Pathways > Virus Protease

Product Information

• Catalog No.: HY-158763
• CAS No.: 856242-63-2
• Molecular Formula: C32H48N4O7
• Molecular Weight: 600.75
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source